FDA Compounding Quality Center of Excellence: Ten Years of Regulated Outsourcing Facilities: A Decade of Progress, But More to Do – (Sept. 11th-13th) Virtual Conference

The MediZap team spent 3 days engaged in all virtual meeting topics and have created a downloadable PDF document that incorporates highlights and learnings we have gathered from this conference. 

Topics included:

  • Prohibition on wholesaling under section 503B of the Federal Food, Drug, and Cosmetic Act
  • Stakeholder Perspective: 503Bs as Partners to Providers: Benefits and Challenges
  • Quality Throughout the Supply Chain
  • Drug Shortages
  • Managing State Regulatory Challenges
  • Stakeholder Perspective: Purchasing and Forecasting: How it Works
  • Product Complaints and Investigations
  • Process Validation and Automation

Older Post